Literature DB >> 8614280

Isolation of anti-leukemia compounds from Citrus reticulata.

N K Mak1, Y L Wong-Leung, S C Chan, J Wen, K N Leung, M C Fung.   

Abstract

In vitro effects of medicinal plant extracts from the pericarpium of Citrus reticulata (cv Jiao Gan) (PCRJ) on the growth and differentiation of a recently characterized murine myeloid leukemic cell clone WEHI 3B (JCS) were investigated. Extracts of PCRJ not only inhibited the proliferation of JCS cells in a dose dependent manner, but also induced differentiation of JCS cells into macrophages and granulocytes. Morphological differentiation of PCRJ treated JCS cells was associated with an increase in phagocytic activity of the cells. Furthermore, both in vitro clonogenicity and in vivo growth of PCRJ treated JCS leukemic cells in syngeneic BALB/c mice were significantly reduced. The survival rate of mice receiving PCRJ treated JCS tumour cells was also increased. Using 1H-NMR, 13C-NMR, and GC/MS, two active components isolated from PCRJ were identified as nobiletin and tangeretin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8614280     DOI: 10.1016/0024-3205(96)00088-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  Anti-inflammatory protein of Schistosoma japonicum directs the differentiation of the WEHI-3B JCS cells and mouse bone marrow cells to macrophages.

Authors:  Shaomin Hu; Linlin Yang; Zhongdao Wu; Nai Ki Mak; Kwok Nam Leung; Ming Chiu Fung
Journal:  J Biomed Biotechnol       Date:  2010-03-02

Review 2.  Chemopreventive Agents and Inhibitors of Cancer Hallmarks: May Citrus Offer New Perspectives?

Authors:  Santa Cirmi; Nadia Ferlazzo; Giovanni E Lombardo; Alessandro Maugeri; Gioacchino Calapai; Sebastiano Gangemi; Michele Navarra
Journal:  Nutrients       Date:  2016-11-04       Impact factor: 5.717

3.  The citrus flavonoid, nobiletin, inhibits peritoneal dissemination of human gastric carcinoma in SCID mice.

Authors:  A Minagawa; Y Otani; T Kubota; N Wada; T Furukawa; K Kumai; K Kameyama; Y Okada; M Fujii; M Yano; T Sato; A Ito; M Kitajima
Journal:  Jpn J Cancer Res       Date:  2001-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.